These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1806624)

  • 21. [Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients].
    Besançon G; Cousin R; Guitton B; Lavergne F
    Encephale; 1993; 19(4):341-5. PubMed ID: 8275922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind multicentre trial comparing the efficacy and side-effects of mianserin and chlorimipramine in depressed in- and outpatients.
    Pinder RM; Blum A; Stulemeijer SM; Barres M; Molczadzki M; Rigaud A; Charbaut J; Israel L; Kammerer T
    Int Pharmacopsychiatry; 1980; 15(4):218-27. PubMed ID: 7021447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
    Siegfried K; O'Connolly M
    Int Clin Psychopharmacol; 1986 Jul; 1(3):231-43. PubMed ID: 3549874
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
    Fabre LF
    J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mianserin versus amitriptyline for depression: a double-blind 6-week trial.
    Rabkin JG; McGrath PJ; Quitkin FM; Fyer A; Stewart JW; Liebowitz MR; Markowitz J
    Neuropsychobiology; 1984; 12(4):224-8. PubMed ID: 6398862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
    Daléry J; Aubin V
    Encephale; 2001; 27(1):71-81. PubMed ID: 11294041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin.
    van Heeringen K; Zivkov M
    Br J Psychiatry; 1996 Oct; 169(4):440-3. PubMed ID: 8894194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical efficacy and side-effects of mianserin and nortriptyline in depressed out-patients: a double-blind randomized trial.
    Hoc J
    Curr Med Res Opin; 1982; 8(4):282-9. PubMed ID: 6759061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline.
    Szegedi A; Wetzel H; Angersbach D; Philipp M; Benkert O
    J Affect Disord; 1997 Sep; 45(3):167-78. PubMed ID: 9298430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brofaromine versus lithium addition to maprotiline. A double-blind study in maprotiline refractory depressed outpatients.
    Hoencamp E; Haffmans PM; Dijken WA; Hoogduin CA; Nolen WA; van Dyck R
    J Affect Disord; 1994 Mar; 30(3):219-27. PubMed ID: 8006248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
    Delini-Stula A; Mikkelsen H; Angst J
    J Affect Disord; 1995 Oct; 35(1-2):21-30. PubMed ID: 8557884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind, placebo-controlled study comparing mianserin and amitriptyline in moderately depressed outpatients.
    Wilcox CS; Cohn JB; Katz BB; Mijares CP; Guarino JJ; Panagides J; DeFrancisco DF
    Int Clin Psychopharmacol; 1994; 9(4):271-9. PubMed ID: 7868849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison.
    Pecknold JC; Familamiri P; McClure DJ; Elie R; Chang H
    J Clin Psychiatry; 1985 May; 46(5):166-71. PubMed ID: 2859273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients?
    Barak Y; Kimhi R; Weizman R
    Int Clin Psychopharmacol; 2000 Jan; 15(1):53-6. PubMed ID: 10836288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.
    Montgomery S; Cronholm B; Asberg M; Montgomery DB
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):77S-80S. PubMed ID: 341948
    [No Abstract]   [Full Text] [Related]  

  • 37. Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people.
    Phanjoo AL; Wonnacott S; Hodgson A
    Acta Psychiatr Scand; 1991 Jun; 83(6):476-9. PubMed ID: 1909083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
    de Jonghe F; Swinkels J; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
    Kasper S; Voll G; Vieira A; Kick H
    Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mianserin and doxepin in the treatment of outpatient depression with anxiety.
    Khan MC; Bennie EH; Stulemeijer SM; Ravens MA
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):213S-218S. PubMed ID: 6824555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.